The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis

Abstract

Very little is known about the role of metabolic regulatory mechanisms in platelet activation and thrombosis. Dimeric pyruvate kinase M2 (PKM2) is a crucial regulator of aerobic glycolysis that facilitates the production of lactate and metabolic reprogramming. Herein, we report that limiting PKM2 dimer formation, using a small molecule inhibitor ML265, negatively regulates lactate production and glucose uptake in human and murine stimulated platelets. Furthermore, limiting PKM2 dimer formation reduced agonist-induced platelet activation, aggregation, clot retraction, and thrombus formation under arterial shear stress in vitro in both human and murine platelets. Mechanistically, limiting PKM2 dimerization downregulated PI3 kinase-mediated Akt /GSK3 signaling in human and murine platelets. To provide further evidence for the role of PKM2 in platelet function, we generated a megakaryocyte or platelet-specific PKM2-/- mutant strain (PKM2fl/flPF4Cre+). Platelet-specific PKM2 deficient mice exhibited impaired agonist-induced platelet activation, aggregation, clot retraction, PI3 kinase-mediated Akt /GSK3 signaling, and were less susceptible to arterial thrombosis in FeCl3-induced carotid and laser-injury induced mesenteric artery thrombosis models, without altering hemostasis. Wild-type mice treated with ML265 were less susceptible to arterial thrombosis with unaltered tail bleeding times. These findings reveal a major role for PKM2 in coordinating multiple aspects of platelet function, from metabolism to cellular signaling to thrombosis, and implicate PKM2 as a potential target for antithrombotic therapeutic intervention.

GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism

“…4 F, right). TEPP-46, a small molecule inhibitor, could limit PKM2 dimer formation [ 32 , 33 ]. We found that TEPP-46 was sufficient to reverse the GTPBP4-overexpression-mediated ECAR increase in GTPBP4 OE PLC/PRF/5 cells ( Fig.…”

Salvianolic Acid B Suppresses Non-Small-Cell Lung Cancer Metastasis through PKM2-Independent Metabolic Reprogramming

“…PKM2 is a central regulator of aerobic glycolysis of cancer cells, which accelerates lactate production as well as metabolic reprogramming [ 21 ]. Our western blotting showed that 200 μ M Sal B-treated NCI-H2030 and NCI-H1650 cells displayed remarkably reduced expression of PKM2 and p-PKM2 in comparison to controls (Figures 4(a) – 4(f) ).…”

PD-L1 Regulates Platelet Activation and Thrombosis via Caspase-3/GSDME Pathway

“…For the FeCl 3 -induced thrombosis model, exogenous carboxyfluorescein succinimidyl ester (CFSE)–labeled platelet was infused into the tail vein. Mice were anaesthetized using 1% pentobarbital, then the common carotid artery was carefully exposed and kept moist by super-fusion with warm (∼37°C) saline, a filter paper (5 × 3 mm) saturated with 5% ferric chloride (FeCl 3 ) solution was applied topically for 1 min, the thrombus formation in the injured carotid vessel was monitored using a Nikon A1RMP + Two-Photon Microscope ( Nayak et al, 2021 ), Time to occlusion exceeding 30 min was noted as 30 min. The time to form occlusive thrombus was considered as the time required for blood to stop flowing completely for >1 min.…”